AC104699.1.1

Gene basic information

SymbolAC104699.1.1
Tissueovary,
Cancerovarian cancer,


Description

LncRNA AC104699.1.1 is down-regulated in ovarian cancer. It could significantly divide the late-stage patients into high- and low-risk groups. Moreover, the expression level of AC104699.1.1 is associated with a decreased risk of survival. Low-risk groups always have higher expression levels of AC104699.1.1 than the high-risk. In addition, AC104699.1.1 is significantly associated with patient progression-free survival. Besides, AC104699.1.1 is involved in immune- and cell cycle-associated processes (1).


Cancer related information

download as excel csv txt

LncRNA tissue cancer type expression level oncogene/suppress gene pathway binding gene/factor associated gene/factor proliferation apoptosis migration EMT invasion metastasis prognosis tag PMID
0 AC104699.1.1 ovary ovarian cancer down TS immune-associated genes + 26631459

Expression profile

adipose adrenal brain breast colon heart kidney leukocyte liver lung lymph node ovary prostate skeletal muscle testis thyroid tissue 0.0 0.5 1.0 1.5 2.0 2.5 3.0 fpkm 0.0 3.0 1.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.7 0.3 0.0 0.6 0.2 0.0 AC104699.1.1

Expression profile in human body map

TCGA-BLCA TCGA-BRCA TCGA-CESC TCGA-HNSC TCGA-KICH TCGA-KIRC TCGA-KIRP TCGA-LIHC TCGA-LUAD TCGA-LUSC TCGA-PRAD TCGA-STAD TCGA-THCA TCGA-UCEC tissue 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 fpkm AC104699.1.1 type normal tumor

Expression profile in TCGA


Genomic feature visualization


Sequence

Literature

[1]. Guo Q, Cheng Y, Liang T, He Y, Ren C, et al. (2015). Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep 5: 17683. link pubmed



© Bioinformatics Group of XTBG